Delivery Order SPE2DB22D2007-SPE2DB25FJ4BR
- Not listed
- The U.S. Department of Defense's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on June 16, 2025, for the supply of Ojjaara 100 mg tablets in quantities of 30 units. This firm fixed-price delivery order, valued at $17,912.32, is scheduled for completion by July 9, 2025, and will be performed at the company's corporate office location in Conshohocken, Pennsylvania. The award represents a non-competitive, competitive delivery order placement under an existing contract...
- The Defense Logistics Agency awarded a delivery order valued at $17,849.85 to AmerisourceBergen Drug Corp for supply of Ojjaara 200 mg tablets in 30-count units. The contract, which is non-set-aside and competitively awarded, carries a firm fixed price structure with performance completion targeted for June 23, 2025. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will execute this delivery order under a broader Indefinite Delivery Contract with the DLA Troop Support...
- The Defense Logistics Agency awarded a $17,849.85 delivery order to AmerisourceBergen Drug Corp for 200 mg Ojjaara tablets in quantities of 30 units, with an ultimate completion date of July 7, 2025. This firm fixed-price delivery order, issued on June 12, 2025, represents a competitively awarded contract with no set-aside designation. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is a child contract issued under...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on August 28, 2025, for the supply of Ojjaara 200 mg tablets in packages of 30 units. This competitively awarded, non-set-aside contract carries a ceiling value of $17,849.85 with firm fixed pricing and is scheduled for completion by September 19, 2025. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location in that same municipality....
- The Defense Logistics Agency has awarded a delivery order valued at $17,849.85 to AmerisourceBergen Drug Corp for the supply of Ojjaara 200 mg tablets in quantities of 30 units. This competitively awarded, firm fixed-price contract was executed on August 5, 2025, with an ultimate completion date of August 26, 2025. The pharmaceutical products will be delivered to the company's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child contract under...
- The Defense Logistics Agency (DLA) awarded AmerisourceBergen Drug Corp a delivery order valued at $17,849.85 on September 9, 2025, for the supply of Ojjaara 200 mg tablets in quantities of 30. This firm fixed-price delivery order, with an ultimate completion date of September 30, 2025, represents a non-set-aside, competitively awarded contract supporting federal medical procurement needs. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania....
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 2, 2025, for the supply of Ojjaara 200 mg tablets in quantities of 30 units. This is a firm fixed price delivery order with a ceiling value of $17,849.85 and an ultimate completion date of September 23, 2025. The contract carries no set-aside designation, indicating it was competitively awarded. The place of performance is AmerisourceBergen's corporate office location in Conshohocken,...
- The Defense Logistics Agency (DLA) awarded a $17,849.85 firm fixed-price delivery order to AmerisourceBergen Drug Corp on August 4, 2025, for the supply of Ojjaara 200 mg tablets in quantities of 30 units. The contract, which represents a child award under AmerisourceBergen's larger IDC with DLA, is scheduled for completion by August 25, 2025. The award was made on a competitive basis with no set-aside designation, and the pharmaceutical products will be delivered to the company's corporate...
- This delivery order, valued at $35,699.72 with a firm fixed price, was awarded on September 8, 2025, to AmerisourceBergen Drug Corp for the supply of Ojjaara 200 mg tablets in 30-count units. The award is a non-set-aside competitive contract with an ultimate completion date of September 29, 2025, and is performed at the contractor's facility in Conshohocken, Pennsylvania. The contract is funded by the Defense Logistics Agency's Medical Supply Chain division and represents a child order under...
- The Defense Logistics Agency awarded a $17,849.85 delivery order to AmerisourceBergen Drug Corp for OJJAARA 200 mg tablets (30-count units) on July 14, 2025, with an ultimate completion date of August 4, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, one of the nation's leading pharmaceutical distributors and...
- SPE2DB22D2007Indefinite Delivery Contract
- SPE2DB22D2007-SPE2DB25FJ4BRDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 19, 2025, for the supply of Ojjaara 200 mg tablets in 30-count packaging. This firm fixed-price delivery order, valued at $17,849.85, represents a non-competitive, non-set-aside award to be fulfilled at the contractor's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of September 10, 2025. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.99 billion comprehensive pharmaceutical support vehicle extending through December 2026 that enables the company to supply a broad range of medications and medical supplies to support military healthcare programs globally. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, regularly fulfills federal medical procurement needs through competitively awarded contracts with the Defense Logistics Agency and its Medical Supply Chain. The company's extensive portfolio of federal awards demonstrates its capability to deliver diverse pharmaceutical products across multiple therapeutic domains, from brand-name and generic medications to specialized medical supplies. This delivery order for Ojjaara tablets exemplifies the company's ongoing role as a critical vendor supporting military and veteran healthcare systems through the DLA's medical supply chain operations.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $17.8k | 8/19/25 |